Points to consider for studies of work participation in people with inflammatory arthritis
Precision medicine becomes more accessible for Australians with cancer
24 June 2021Many cancer patients may need a sequential one-two punch of immunotherapies
24 June 2021Points to consider for studies of work participation in people with inflammatory arthritis
Understanding work participation is important, but the way in which this is defined and measured in clinical trials is not always the same, which has made it hard to compare data. EULAR set up a taskforce to draft points to consider when designing studies that use work participation as a measure. The taskforce included doctors, experts and patients from 11 countries. They used the published evidence to draw up a set of points to consider.
